Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FSZ46
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $98,450
Award facts
- Contract value 100% obligated
- $98,449.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, a delivery order valued at $98,449.80 on August 28, 2025, for the supply of Keytruda 100 mg/4 ml vials. The contract is firm fixed-price with an ultimate completion date of September 19, 2025, and will be performed in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026, which establishes the company as a primary supplier of pharmaceutical products to Department of Defense healthcare facilities worldwide. No set-aside designation was applied to this award.
DMS Pharmaceutical Group leverages its status as a woman-owned small business to compete effectively in federal pharmaceutical procurement. The company has demonstrated consistent success in securing delivery orders for an extensive portfolio of pharmaceutical items, ranging from oncology medications and biologics to vaccines and specialty medical supplies. Keytruda, a leading immunotherapy treatment, represents the type of high-value pharmaceutical product the company routinely distributes to military and federal healthcare systems. The firm's positioning within the federal supply chain underscores the critical role small business contractors play in supporting Department of Defense medical supply requirements.
Quick answers
Who was awarded contract SPE2DB25FSZ46?
SPE2DB25FSZ46 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 28, 2025.
How much is contract SPE2DB25FSZ46 worth?
The government has obligated $98,450 on SPE2DB25FSZ46.
Is contract SPE2DB25FSZ46 an order under another contract?
Yes. SPE2DB25FSZ46 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.
Was contract SPE2DB25FSZ46 competed?
The extent of competition for SPE2DB25FSZ46 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award